KI
KNSA icon

Kapitalo Investimentos’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Kapitalo Investimentos’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,071
Closed -$141K – 598
2023
Q1 		$141K Buy
13,071
+7,271
+125% +$95.8K 0.05% 234
2022
Q4 		$86.9K Buy
+5,800
New +$84.4K 0.07% 81

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Kapitalo Investimentos's KNSA Position: Q2 2023 in Review

Kapitalo Investimentos sold out of Kiniksa Pharmaceuticals (KNSA) in Q2 2023, closing a stake of 13,071 shares — an estimated $141K sold.

Kapitalo Investimentos first reported a position in KNSA in Q4 2022 and held it in 2 quarters. The position peaked at $141K in Q1 2023. 127 funds tracked by Wall St. Rank hold KNSA as of Q2 2023.

  • Kapitalo Investimentos reported no remaining Kiniksa Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Kapitalo Investimentos sold 13,071 Kiniksa Pharmaceuticals shares in Q2 2023, an estimated $141K.
  • Kapitalo Investimentos first reported a position in Kiniksa Pharmaceuticals in Q4 2022 and held it in 2 quarters.
  • Kapitalo Investimentos's Kiniksa Pharmaceuticals position peaked at $141K in Q1 2023.
  • 127 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2023.

Based on Kapitalo Investimentos's 13F filing for Q2 2023, filed 29 Mar 2024.